www.rollcall.com

www.rollcall.com
Share

www.rollcall.com

 •  October 20

President Donald Trump is considering launching a bipartisan task force to investigate the rising cost of prescription drugs, sources with knowledge of the discussion say. The announcement could come as early as next week, but the sources caution that discussions remain in the early stages and are still fluid. They say it could be part of an...

www.rollcall.com

 •  August 14

A Senate-passed bill intended to help dying patients access experimental drugs will likely face lengthier deliberations in the House. While the Senate fast-tracked the bill on Aug. 3, the House will likely subject it to a hearing and markup before bringing it up to a vote, according to congressional aides and a lobbyist. The bill would reduce some...

www.rollcall.com

 •  June 23

BY ANDREW SIDDONS AND JOE WILLIAMS The Trump administration might seek to roll back regulations in pursuit of faster drug approvals, promoting drug competition and new payment models for federal health insurance programs, according to a draft executive order obtained by CQ Roll Call. Some of the items listed would benefit pharmaceutical companies,...